Bill > HR4841

This bill aims to comprehensively address stomach cancer by requiring two major studies: one by the National Cancer Institute (NCI) and another by the Department of Defense. The NCI study will conduct an extensive review of stomach cancer in the United States, examining current incidence rates, risk factors, screening availability, and awareness levels. The review will specifically investigate key areas such as H. pylori infection, endoscopic screening effectiveness, and risk factors among different populations. The NCI will be required to submit a report to Congress within 18 months that includes recommendations for defining high-risk populations, improving early detection methods, establishing screening guidelines, and enhancing research and treatment strategies. Simultaneously, the Department of Defense will conduct a separate study focusing on stomach cancer among military personnel, exploring incidence rates, service-related risk factors, screening availability, and potential disparities in outcomes based on race, ethnicity, gender, and deployment history. This study will also aim to develop recommendations for reducing stomach cancer incidence and mortality within military and veteran health systems. The bill is motivated by the finding that stomach cancer affects approximately 30,300 new cases annually and disproportionately impacts certain racial and ethnic groups, with a goal of increasing awareness, prevention, and early detection.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/119th-congress/house-bill/4841/all-info